Summary:
This is a research study of an investigational combination inhaler to be used for a once daily dosing in the treatment of asthma.
Qualified Participants Must:
• Be 12 years of age or older
•
Have been using an approved dose of an ICS for at least 12 weeks preceding visit 1
•
Have a history of an asthma exacerbation in the previous 12 months requiring steroids or ER/hospitalization
Qualified Participants May Receive:
Study related care at no charge including physical exams, labs and study medication.